Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Aberrant nucleocytoplasmic localization of the retinoblastoma tumor suppressor protein in human cancer correlates with moderate/poor tumor differentiation.

Jiao W, Lin HM, Datta J, Braunschweig T, Chung JY, Hewitt SM, Rane SG.

Oncogene. 2008 May 15;27(22):3156-64. Epub 2007 Dec 10.

PMID:
18071317
2.

Nucleocytoplasmic shuttling of the retinoblastoma tumor suppressor protein via Cdk phosphorylation-dependent nuclear export.

Jiao W, Datta J, Lin HM, Dundr M, Rane SG.

J Biol Chem. 2006 Dec 8;281(49):38098-108. Epub 2006 Oct 16.

3.
4.

MyoD induces apoptosis in the absence of RB function through a p21(WAF1)-dependent re-localization of cyclin/cdk complexes to the nucleus.

Peschiaroli A, Figliola R, Coltella L, Strom A, Valentini A, D'Agnano I, Maione R.

Oncogene. 2002 Nov 21;21(53):8114-27. Erratum in: Oncogene. 2003 Mar 20;22(11):1747.

5.

Differential requirements for ras and the retinoblastoma tumor suppressor protein in the androgen dependence of prostatic adenocarcinoma cells.

Fribourg AF, Knudsen KE, Strobeck MW, Lindhorst CM, Knudsen ES.

Cell Growth Differ. 2000 Jul;11(7):361-72.

6.

Distinct and nonoverlapping roles for pRB and cyclin D:cyclin-dependent kinases 4/6 activity in melanocyte survival.

Yu BD, Becker-Hapak M, Snyder EL, Vooijs M, Denicourt C, Dowdy SF.

Proc Natl Acad Sci U S A. 2003 Dec 9;100(25):14881-6. Epub 2003 Nov 20.

8.

Cyclin/CDK regulates the nucleocytoplasmic localization of the human papillomavirus E1 DNA helicase.

Deng W, Lin BY, Jin G, Wheeler CG, Ma T, Harper JW, Broker TR, Chow LT.

J Virol. 2004 Dec;78(24):13954-65.

9.

Cyclin D1 splice variants. Differential effects on localization, RB phosphorylation, and cellular transformation.

Solomon DA, Wang Y, Fox SR, Lambeck TC, Giesting S, Lan Z, Senderowicz AM, Conti CJ, Knudsen ES.

J Biol Chem. 2003 Aug 8;278(32):30339-47. Epub 2003 May 12. Erratum in: J Biol Chem. 2004 Jul 16;279(29):30914.

10.

Modulation of nucleocytoplasmic trafficking by retention in cytoplasm or nucleus.

Roth DM, Harper I, Pouton CW, Jans DA.

J Cell Biochem. 2009 Aug 15;107(6):1160-7. doi: 10.1002/jcb.22218.

PMID:
19507231
11.

Critical role of cyclin D1 nuclear import in cardiomyocyte proliferation.

Tamamori-Adachi M, Ito H, Sumrejkanchanakij P, Adachi S, Hiroe M, Shimizu M, Kawauchi J, Sunamori M, Marumo F, Kitajima S, Ikeda MA.

Circ Res. 2003 Jan 10;92(1):e12-9.

12.

Modeling the effect of the RB tumor suppressor on disease progression: dependence on oncogene network and cellular context.

Dean JL, McClendon AK, Stengel KR, Knudsen ES.

Oncogene. 2010 Jan 7;29(1):68-80. doi: 10.1038/onc.2009.313. Epub 2009 Oct 5.

PMID:
19802012
13.

Disruption of the Rb--Raf-1 interaction inhibits tumor growth and angiogenesis.

Dasgupta P, Sun J, Wang S, Fusaro G, Betts V, Padmanabhan J, Sebti SM, Chellappan SP.

Mol Cell Biol. 2004 Nov;24(21):9527-41.

15.

Multiple mechanisms of p16INK4A inactivation in non-small cell lung cancer cell lines.

Shapiro GI, Park JE, Edwards CD, Mao L, Merlo A, Sidransky D, Ewen ME, Rollins BJ.

Cancer Res. 1995 Dec 15;55(24):6200-9.

17.
18.

[Molecular mechanisms controlling the cell cycle: fundamental aspects and implications for oncology].

Viallard JF, Lacombe F, Belloc F, Pellegrin JL, Reiffers J.

Cancer Radiother. 2001 Apr;5(2):109-29. Review. French.

PMID:
11355576
19.

The molecular basis of cancer suppression by the retinoblastoma gene.

Lee WH.

Princess Takamatsu Symp. 1989;20:159-70.

PMID:
2488231
20.

Supplemental Content

Support Center